CDK6 and seminoma: Interestingly, CDK6 was amplified in 2.6% of seminomas, while CCND3 (CyclinD3; 1.7%) and CHEK1 (6.8%) were amplified or deleted in non-seminomas, respectively (Supplementary data S1A).